Skip to record
CompaniesSUPERNUS PHARMACEUTICALS, INC.

SUPERNUS PHARMACEUTICALS, INC.

Enterprise record · Agent view

Version public-1:d751713988987e9331980363e24189ce

Agent view

Machine access

Formats and access paths for the same published Governance Record shown in Human View.

alpha:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6 · public-1:d751713988987e9331980363e24189ce

Published Claims
21
Cited sources
6
Record version
public-1:d751713988987e9331980363e24189ce

Alpha Governance Record

Typed governance sections assembled from the published Claims. Retrieve one section at a time through the scoped HTTP resources below; MCP URIs are the resource contract served by the Alpha MCP server.

Alpha Record ID
alpha:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6
Schema version
alpha-governance-record-v2
Record version
public-1:d751713988987e9331980363e24189ce
Ontology version
alpha-governance-ontology-v1
Core contract
alpha-governance-record-core-v2
Predicate registry
alpha-claim-predicates-v1
As of
2026-10-05T21:16:34.119281+00:00
Published
2026-10-05T15:31:21.915751+00:00
Publication state
PUBLISHED
Verification state
source_reported
Identity ownership
unclaimed
Record Quality
0.83 (strong; readiness ready)
Completeness
0.364 of expected sections for public_company
Evidence coverage
6 evidence records; 6 restricted or unknown rights
Directors
8
Committees
0
Governance events
8

Section coverage

  • identityPUBLISHED
  • corporate_structureNOT_REVIEWED
  • boardPUBLISHED
  • committeesNOT_REVIEWED
  • leadershipPUBLISHED
  • ownershipNOT_REVIEWED
  • financialsNOT_REVIEWED
  • capital_structurePUBLISHED
  • compensationNOT_REVIEWED
  • governanceNOT_REVIEWED
  • shareholder_governanceNOT_REVIEWED
  • auditNOT_REVIEWED
  • legalNOT_REVIEWED
  • riskNOT_REVIEWED
  • cyberNOT_REVIEWED
  • ai_governanceNOT_REVIEWED
  • agent_governanceRESTRICTED
  • markets_externalNOT_REVIEWED
  • eventsPUBLISHED
  • relationshipsPUBLISHED
  • assessmentsPUBLISHED
  • evidencePUBLISHED

Rights constraints

public_retrieval
allowed
agent_retrieval
allowed
redistribution
not_granted
model_training
not_granted
commercial_use
not_specified
relationship_pathfinding
not_granted
direct_contact
not_granted

Scoped resources

Scoped resource URIs and live HTTP equivalents
SectionMCP URIHTTPState
recordalpha://company/supernus-pharmaceuticals-incalias alpha://companies/supernus-pharmaceuticals-inc/api/public/companies/supernus-pharmaceuticals-inc?format=recordPUBLISHED
identityalpha://company/supernus-pharmaceuticals-inc/identity/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=identityPUBLISHED
corporate_structurealpha://company/supernus-pharmaceuticals-inc/corporate-structure/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=corporate-structureNOT_REVIEWED
boardalpha://company/supernus-pharmaceuticals-inc/board/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=boardPUBLISHED
committeesalpha://company/supernus-pharmaceuticals-inc/committees/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=committeesNOT_REVIEWED
leadershipalpha://company/supernus-pharmaceuticals-inc/leadership/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=leadershipPUBLISHED
ownershipalpha://company/supernus-pharmaceuticals-inc/ownership/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=ownershipNOT_REVIEWED
financialsalpha://company/supernus-pharmaceuticals-inc/financials/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=financialsNOT_REVIEWED
capital_structurealpha://company/supernus-pharmaceuticals-inc/capital-structure/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=capital-structurePUBLISHED
compensationalpha://company/supernus-pharmaceuticals-inc/compensation/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=compensationNOT_REVIEWED
governancealpha://company/supernus-pharmaceuticals-inc/governance/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=governanceNOT_REVIEWED
shareholder_governancealpha://company/supernus-pharmaceuticals-inc/shareholder-governance/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=shareholder-governanceNOT_REVIEWED
auditalpha://company/supernus-pharmaceuticals-inc/audit/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=auditNOT_REVIEWED
legalalpha://company/supernus-pharmaceuticals-inc/legal/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=legalNOT_REVIEWED
riskalpha://company/supernus-pharmaceuticals-inc/risk/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=riskNOT_REVIEWED
cyberalpha://company/supernus-pharmaceuticals-inc/cyber/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=cyberNOT_REVIEWED
ai_governancealpha://company/supernus-pharmaceuticals-inc/ai-governance/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=ai-governanceNOT_REVIEWED
agent_governancealpha://company/supernus-pharmaceuticals-inc/agents/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=agentsRESTRICTED
markets_externalalpha://company/supernus-pharmaceuticals-inc/ecosystem/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=ecosystemNOT_REVIEWED
eventsalpha://company/supernus-pharmaceuticals-inc/events/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=eventsPUBLISHED
relationshipsalpha://company/supernus-pharmaceuticals-inc/relationships/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=relationshipsPUBLISHED
assessmentsalpha://company/supernus-pharmaceuticals-inc/assessments/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=assessmentsPUBLISHED
evidencealpha://company/supernus-pharmaceuticals-inc/evidence/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=evidencePUBLISHED

HTTP resources are live on this Registry. MCP URIs are the published resource contract; availability on mcp.alpha.ac is reported by the server card, not assumed here.

Formats

https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc.md

Open in new tabDownload
# SUPERNUS PHARMACEUTICALS, INC.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 21 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-05T15:31:21.915751+00:00 |
| Last reviewed | 2026-10-05T15:31:21.915751+00:00 |

## Identity

- Legal name: SUPERNUS PHARMACEUTICALS, INC.
- Display name: SUPERNUS PHARMACEUTICALS, INC.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce |
| As of | 2026-10-05T21:16:34.119281+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.83 |
| Directors | 8 |
| Committees | 0 |
| Governance events | 8 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Bethany L. Sensenig: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:6
- Carrolee Barlow: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:7
- Frederick M. Hudson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2010-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:9
- Georges Gemayel: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:10
- Jack A. Khattar: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2005-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:12
- Carrolee Barlow, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:8
- Charles W. Newhall, III: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:5
- Georges Gemayel, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:11

## Executive leadership

- Jonathan Rubin: Senior Vice President, Chief Medical Officer, Research and Development. Status: current. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:15
- Prat S. Bhatt: Senior Vice President of Intellectual Property, Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:18
- William Todd Horich: Senior Vice President, Commercial Operations, Marketing, and Market Access. Status: current. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:20
- Frank Mottola: Senior Vice President, Chief Technical Operations Officer. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:13
- Jack A. Khattar: President, Chief Executive Officer and Secretary [CEO]. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:14
- Jonathan Rubin, M.D.: Senior Vice President, Chief Medical Officer, Research and Development. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:16
- Padmanabh P. Bhatt, Ph.D.: Senior Vice President of Intellectual Property, Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:17
- Timothy C. Dec: Senior Vice President, Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:19
- William Todd Horich, Ph.D., MBA: Senior Vice President, Commercial Operations, Marketing, and Market Access. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:21

## Governance events

- EXECUTIVE_APPOINTED: Jonathan Rubin executive of SUPERNUS PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:executive_appointed:1c0biz1
- EXECUTIVE_APPOINTED: Prat S. Bhatt executive of SUPERNUS PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:executive_appointed:1yto49v
- EXECUTIVE_APPOINTED: William Todd Horich executive of SUPERNUS PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:executive_appointed:11woshw
- DIRECTOR_APPOINTED: Bethany L. Sensenig seat on SUPERNUS PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:1k4292i
- DIRECTOR_APPOINTED: Carrolee Barlow seat on SUPERNUS PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:12agzf9
- DIRECTOR_APPOINTED: Georges Gemayel seat on SUPERNUS PHARMACEUTICALS, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:1czpo6m
- DIRECTOR_APPOINTED: Frederick M. Hudson seat on SUPERNUS PHARMACEUTICALS, INC., effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:17un2wn
- DIRECTOR_APPOINTED: Jack A. Khattar seat on SUPERNUS PHARMACEUTICALS, INC., effective 2005-01-01. Effective: 2005-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:1xydjm2

## Scoped resources

- `alpha://company/supernus-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record
- `alpha://company/supernus-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=identity
- `alpha://company/supernus-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=corporate-structure
- `alpha://company/supernus-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=board
- `alpha://company/supernus-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=committees
- `alpha://company/supernus-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=leadership
- `alpha://company/supernus-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=ownership
- `alpha://company/supernus-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=financials
- `alpha://company/supernus-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=capital-structure
- `alpha://company/supernus-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=compensation
- `alpha://company/supernus-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=governance
- `alpha://company/supernus-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=shareholder-governance
- `alpha://company/supernus-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=audit
- `alpha://company/supernus-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=legal
- `alpha://company/supernus-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=risk
- `alpha://company/supernus-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=cyber
- `alpha://company/supernus-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=ai-governance
- `alpha://company/supernus-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=agents
- `alpha://company/supernus-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=ecosystem
- `alpha://company/supernus-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=events
- `alpha://company/supernus-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=relationships
- `alpha://company/supernus-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=assessments
- `alpha://company/supernus-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Charles W. Newhall, III: Chairman of the Board. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Bethany L. Sensenig: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3.
- Carrolee Barlow: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:7. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3.
- Carrolee Barlow, M.D., Ph.D.: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Frederick M. Hudson: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:9. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3.
- Georges Gemayel: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:10. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3.
- Georges Gemayel, Ph.D.: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Jack A. Khattar: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:12. Valid from: 2005-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3.
- Frank Mottola: Senior Vice President, Chief Technical Operations Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Jack A. Khattar: President, Chief Executive Officer and Secretary. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Jonathan Rubin: Senior Vice President, Chief Medical Officer, Research and Development. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:15. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b906e9bd5512ae5922857a6f3bc4c5e1781e5ace0d2330182ae86482fcb5a06.
- Jonathan Rubin, M.D.: Senior Vice President, Chief Medical Officer, Research and Development. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Padmanabh P. Bhatt, Ph.D.: Senior Vice President of Intellectual Property, Chief Scientific Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- Prat S. Bhatt: Senior Vice President of Intellectual Property, Chief Scientific Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:18. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:35115dcc0f5f5152de9e01e9cc8a8f5fd3a6507409b03a6e1c61bc90a029ad86.
- Timothy C. Dec: Senior Vice President, Chief Financial Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.
- William Todd Horich: Senior Vice President, Commercial Operations, Marketing, and Market Access. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:20. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a206dbaad43a30166b663513d1a7c6278478c7f8dbf0b8f33be92d4f3e4c225f.
- William Todd Horich, Ph.D., MBA: Senior Vice President, Commercial Operations, Marketing, and Market Access. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- SUPERNUS PHARMACEUTICALS, INC.. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9.

## Entity Status

- Public listing published. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9.

## Published Fact

- US. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9.

## Security Listing

- SUPN (NASDAQ). Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc).
- alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8: [SEC DEF 14A 0001104659-26-053111](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm).
- alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3: [DEF 14A tm261453-1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm).
- alpha:projection-evidence:document:9b906e9bd5512ae5922857a6f3bc4c5e1781e5ace0d2330182ae86482fcb5a06: [SUPN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm).
- alpha:projection-evidence:document:35115dcc0f5f5152de9e01e9cc8a8f5fd3a6507409b03a6e1c61bc90a029ad86: [SUPN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm).
- alpha:projection-evidence:document:a206dbaad43a30166b663513d1a7c6278478c7f8dbf0b8f33be92d4f3e4c225f: [SUPN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc)
- [Public Markdown](https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=jsonld)
- MCP resource: `alpha://companies/supernus-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

Connect

REST

MCP tools

Server card: Alpha Terminal · alpha://companies/supernus-pharmaceuticals-inc

  • find_person

    Search Alpha's permission-safe public Profile directory. Returns canonical Alpha person IDs, evidence-backed current roles, assurance state, review time, and limitations. Similar names remain separate candidates.

  • get_claim_evidence

    Retrieve the public source evidence for one permissioned Alpha Profile claim. Returns source tier, URLs, validity, confidence, review time, and limitations.

  • get_company_profile

    Retrieve a public Alpha Company Profile with canonical company identity, active listings, current confirmed board and executive roles, source evidence, explicit permissions, as-of time, and limitations. Private relationships, company administration, and unpublished ratings are excluded.

  • get_current_roles

    Retrieve the current confirmed company and board roles from a public Alpha Profile. Every role includes available source evidence, confidence, verification state, and validity.

  • get_executive_profile

    Retrieve a public Alpha Profile with canonical identity, current verified roles, permissioned claims, claim-level evidence, assurance state, as-of time, and limitations. Private contact, Council activity, and relationships are excluded.

  • get_platform_stats

    Get Alpha platform statistics and data coverage. Returns counts of companies, directors, ratings, filings, and regulations in the Alpha intelligence database.

A2A

Agent card

Follow

Recent Registry updates (general index)

Record-specific changes feed and webhook events: Proposed. No delivery endpoint is published for this record.

Cite

URL
https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc
Version
public-1:d751713988987e9331980363e24189ce
JSON content hash
Unavailable

Evidence sources

  • Alpha canonical company public projection
  • SEC DEF 14A 0001104659-26-053111
  • DEF 14A tm261453-1_def14a.htm
  • SUPN DEF 14A executive officers
  • SUPN DEF 14A executive officers
  • SUPN DEF 14A executive officers